FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2904205732> ?p ?o ?g. }

• W2904205732 endingPage "752" @default.
• W2904205732 startingPage "744" @default.
• W2904205732 abstract "Relapsed or refractory non-Hodgkin lymphomas (NHLs) often carry poor prognosis and pose management challenges. We evaluated the safety and efficacy of dasatinib, a broad-spectrum multi-kinase inhibitor in relapsed/refractory NHL with correlative genomic analysis in a Phase I/II trial. The study included 33 patients with various sub-types of NHL who had received at least one prior therapy. The most common sub-types were diffuse large B-cell lymphoma (24%), follicular lymphoma, grade 1/2 (21%) and peripheral T-cell lymphoma not otherwise specified (PTCL-NOS; 21%). Most patients were heavily pre-treated, including 42% with more than four prior therapies, 67% with rituximab exposure and 24% with prior autologous transplant. In this cohort, dasatinib showed modest activity in evaluable patients with an objective response rate of 29% (7/24) and clinical benefit rate of 71% (17/24). In 32 patients with outcome data, median progression-free survival was 3 months and median overall survival was 22·4 months. There were two patients with sustained complete responses, both with PTCL-NOS histology. The side effect profile was consistent with prior studies, with pleural effusion being the most common non-haematological toxicity. Exploratory genomic analysis showed two cases of PTCL-NOS with sustained response had a common mutation in LRRK2 and high prevalence of FOXO1 mutation in relapsed/refractory follicular lymphoma." @default.
• W2904205732 created "2018-12-22" @default.
• W2904205732 creator A5015628512 @default.
• W2904205732 creator A5041701143 @default.
• W2904205732 creator A5043511420 @default.
• W2904205732 creator A5045676616 @default.
• W2904205732 creator A5051379368 @default.
• W2904205732 creator A5052070772 @default.
• W2904205732 creator A5061471602 @default.
• W2904205732 creator A5064150576 @default.
• W2904205732 creator A5064436224 @default.
• W2904205732 creator A5068152076 @default.
• W2904205732 creator A5069699129 @default.
• W2904205732 creator A5080373697 @default.
• W2904205732 creator A5090315980 @default.
• W2904205732 creator A5091491910 @default.
• W2904205732 date "2018-12-05" @default.
• W2904205732 modified "2023-10-10" @default.
• W2904205732 title "Phase I/II study of dasatinib and exploratory genomic analysis in relapsed or refractory non-Hodgkin lymphoma" @default.
• W2904205732 cites W1555843904 @default.
• W2904205732 cites W1968454115 @default.
• W2904205732 cites W1970244138 @default.
• W2904205732 cites W1970848642 @default.
• W2904205732 cites W1976174817 @default.
• W2904205732 cites W1982210245 @default.
• W2904205732 cites W1985503770 @default.
• W2904205732 cites W1986579589 @default.
• W2904205732 cites W2016465570 @default.
• W2904205732 cites W2027818217 @default.
• W2904205732 cites W2029409133 @default.
• W2904205732 cites W2031345305 @default.
• W2904205732 cites W2034851497 @default.
• W2904205732 cites W2058584439 @default.
• W2904205732 cites W2079116568 @default.
• W2904205732 cites W2082328491 @default.
• W2904205732 cites W2091572955 @default.
• W2904205732 cites W2092606584 @default.
• W2904205732 cites W2104607769 @default.
• W2904205732 cites W2106198555 @default.
• W2904205732 cites W2116153687 @default.
• W2904205732 cites W2133201432 @default.
• W2904205732 cites W2134168335 @default.
• W2904205732 cites W2137348614 @default.
• W2904205732 cites W2150587745 @default.
• W2904205732 cites W2152162065 @default.
• W2904205732 cites W2160981405 @default.
• W2904205732 cites W2163773009 @default.
• W2904205732 cites W2165022781 @default.
• W2904205732 cites W2264636885 @default.
• W2904205732 cites W2294723338 @default.
• W2904205732 cites W2310716991 @default.
• W2904205732 cites W2397234997 @default.
• W2904205732 cites W2461798448 @default.
• W2904205732 cites W2565428667 @default.
• W2904205732 cites W2602156859 @default.
• W2904205732 cites W2624092568 @default.
• W2904205732 cites W2743064314 @default.
• W2904205732 cites W2744261860 @default.
• W2904205732 cites W2976680230 @default.
• W2904205732 cites W4242820529 @default.
• W2904205732 cites W4251003091 @default.
• W2904205732 doi "https://doi.org/10.1111/bjh.15702" @default.
• W2904205732 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8281362" @default.
• W2904205732 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30520026" @default.
• W2904205732 hasPublicationYear "2018" @default.
• W2904205732 type Work @default.
• W2904205732 sameAs 2904205732 @default.
• W2904205732 citedByCount "20" @default.
• W2904205732 countsByYear W29042057322019 @default.
• W2904205732 countsByYear W29042057322020 @default.
• W2904205732 countsByYear W29042057322021 @default.
• W2904205732 countsByYear W29042057322022 @default.
• W2904205732 countsByYear W29042057322023 @default.
• W2904205732 crossrefType "journal-article" @default.
• W2904205732 hasAuthorship W2904205732A5015628512 @default.
• W2904205732 hasAuthorship W2904205732A5041701143 @default.
• W2904205732 hasAuthorship W2904205732A5043511420 @default.
• W2904205732 hasAuthorship W2904205732A5045676616 @default.
• W2904205732 hasAuthorship W2904205732A5051379368 @default.
• W2904205732 hasAuthorship W2904205732A5052070772 @default.
• W2904205732 hasAuthorship W2904205732A5061471602 @default.
• W2904205732 hasAuthorship W2904205732A5064150576 @default.
• W2904205732 hasAuthorship W2904205732A5064436224 @default.
• W2904205732 hasAuthorship W2904205732A5068152076 @default.
• W2904205732 hasAuthorship W2904205732A5069699129 @default.
• W2904205732 hasAuthorship W2904205732A5080373697 @default.
• W2904205732 hasAuthorship W2904205732A5090315980 @default.
• W2904205732 hasAuthorship W2904205732A5091491910 @default.
• W2904205732 hasBestOaLocation W29042057321 @default.
• W2904205732 hasConcept C121332964 @default.
• W2904205732 hasConcept C126322002 @default.
• W2904205732 hasConcept C142424586 @default.
• W2904205732 hasConcept C143998085 @default.
• W2904205732 hasConcept C2776694085 @default.
• W2904205732 hasConcept C2777058707 @default.
• W2904205732 hasConcept C2777063308 @default.
• W2904205732 hasConcept C2777583451 @default.
• W2904205732 hasConcept C2778729363 @default.

• next